Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies

MHRA And Afssaps To Assist SUKL

July 2006 | Project News

The UK drugs regulator - the Medicines and Healthcare products Regulatory Agency (MHRA) - and its French counterpart, Afssaps, are to provide training and assistance to the Czech's Republic's body, SUKL, under a twinning programme designed for new members of the

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
EGA Report Criticises EU Patent System

Companies A report published by the European Generic Medicines Association (EGA) has criticised the way in which the EU patent system can be abused by research-based pharmaceutical companies to delay market access...
June 2008
Healthcare Corruption Threatens Eastern Europe

Companies Corruption remains widespread in the former communist nations that joined the EU two years ago, despite efforts to counter the problem, according to Transparency International's Corruption Perception...
November 2006
CEE Countries Rank High in Healthcare Value For Money Survey

Companies Certain Central and Eastern European (CEE) countries have scored better than their Western European counterparts in a consumer healthcare value for money survey, despite the region being notorious for...
June 2006
CROs Look To Emerging Europe To Cut Costs

Companies Clinical research organisations (CROs) working on behalf of multinational pharmaceutical companies are increasingly looking towards emerging Europe to their cut
June 2006
CEE Patients Prefer Local Medicines

Companies Patients in the majority of Central and Eastern Europe countries prefer to receive a drug produced by a local manufacturer rather than one manufactured by an international firm, according to a survey...
May 2006
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS